Profil
Robert Tighe is currently working as Vice President-Research at TCR2 Therapeutics, Inc. He previously worked as VP-Translational Immunology & Immunopharmacology at Compass Therapeutics, Inc.
Aktive Positionen von Robert Tighe
Unternehmen | Position | Beginn |
---|---|---|
TCR2 THERAPEUTICS INC. | Chief Tech/Sci/R&D Officer | - |
Ehemalige bekannte Positionen von Robert Tighe
Unternehmen | Position | Ende |
---|---|---|
COMPASS THERAPEUTICS, INC. | Corporate Officer/Principal | - |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
Börsennotierte Unternehmen | 1 |
---|---|
COMPASS THERAPEUTICS, INC. | Health Technology |
Private Unternehmen | 1 |
---|---|
TCR2 Therapeutics, Inc.
TCR2 Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology TCR2 Therapeutics, Inc. is a clinical-stage cell therapy company, which engages in the development of biological drugs and engineering T-cells for cancer therapy. It is also involved in the research and collaboration with academic laboratories and industry partners in the field of T-cell immunology, cell therapy, gene editing, and process development. The company was founded by Patrick A. Baeuerle on May 29, 2015 and is headquartered in Cambridge, MA. | Health Technology |